|
Market Cap (3-Jul) $2,136,106,496 (333rd) |
Close (30-Jun) $1.14 |
Volume (30-Jun) 2,606,681 |
Shortsold (19-Jun) 79,324,475 (6.21%) (26th) |
|
52w High $3.37 |
52w Low $0.88 |
P/E 454.55 |
EPS -0.15 |
MSB released this announcement to the ASX on 9 June 2022, 9:34. The announcement is not marked as price sensitive, and is 3 page(s) in length and 168.93kb in size.
You can view all announcements from MSB and see how they appear on a price chart on the announcements page.
At the date of this announcement, MSB was 8.249% short sold according to ASIC data. It was ranked the 12th most shorted stock on the ASX. It remains ranked 26th as of the latest reported data (19 June 2025).
| Other Recent Announcements from MSB | |
|---|---|
| Change of Director's Interest Notice | 13 June 2023, 8:56 |
| Mesoblast Director Appointed to Strategic Advisory Role | 5 June 2023, 9:41 |
| MSB Reports Q3 Financial Results and Operational Highlights | 26 May 2023, 8:32 |
| Mesoblast to Host KOL Event on Chronic Low Back Pain | 9 June 2022, 9:34 |
| Third Quarter Results Presentation | 1 June 2022, 9:34 |
| MSB Q3 Financial Results and Operational Highlights | 1 June 2022, 8:32 |
| Third Quarter Financial Results on Form 6-K | 1 June 2022, 8:24 |
You must be logged in to post a reply.
Mesoblast 